 |
 |
||||||||||||||
|
|
|
OPDC Profile |
|
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is dedicated to developing and commercializing innovative healthcare products, on a global basis, that address unmet medical needs.
The outstanding clinical development and commercialization work of the professionals at OPDC form the cornerstone of global product development and commercialization for Otsuka Pharmaceutical Co., Ltd. OPDC currently has several compounds in development in diverse therapeutic areas.
Employees
Headquarters
Additional Location
Areas of Investigation Cardiovascular Gastrointestinal Ophthalmology Oncology Neuroscience Renal Respiratory
OPDC's Corporate Purpose Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC's) purpose is to be a force that drives the globalization, growth, and success of our pharmaceutical business by collaborating with all Otsuka people.
OPDC'S Corporate Mission Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) will deliver medicines that improve the health and quality of life of patients worldwide.
OPDC'S Core Values •Speed and Agility •Tenacity •Inventiveness •Collaboration •Knowledge |
| * OAPI, OPDC and OMML are subsidiaries of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd.
0109W-0602 |